Mass General Brigham ID Fellows

@mgb-id-fellows.bsky.social

Welcome to the MGB ID Fellowship! Learn more about our program, our current fellows, and our faculty at idfellowship.massgeneralbrigham.org.

New multi-center research by faculty Dr. Obeid, Dr. Young & colleagues highlights severe challenges in treating refractory HSV in stem cell transplant recipients. With high acyclovir resistance & drug toxicity, their findings stress the urgent need for safer, oral antivirals. #IDSky

Refractory Mucocutaneous Infections by Herpes Simplex Virus (HSV) in Hematopoietic Cell Transplant Recipients: A Real-world, Multicenter Study

A total of 55.2% HCT recipients with refractory HSV healed completely at a median of 38 days of therapy. Seventy-five percent of patients received foscarne

academic.oup.com

😃 We are so excited to see applications pouring in for the July 2027 Mass General Brigham ID Fellowship class! We look forward to welcoming another ten amazing fellows to our city, our hospitals, and our extensive research facilities. Learn more about us at idfellowship.massgeneralbrigham.org

Mass General Brigham Infectious Diseases Fellowship – a combined program of Brigham and Women's Hospital and the Massachusetts General Hospital

idfellowship.massgeneralbrigham.org